A New Strategy for Discontinuation of Dual Antiplatelet Therapy: The RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)

Study Questions:

What is the safety and efficacy of shorter duration (3 months) dual antiplatelet therapy (DAPT) after drug-eluting stent (DES) implantation?